Identification and actions of the maresin 1 metabolome in infectious inflammation

Journal of Immunology

Volumn 197, Issue 11, 2016, Pages 4444-4452

  Colas, Romain A ^a,b   Dalli, Jesmond ^a,b   Chiang, Nan ^a   Vlasakov, Iliyan ^a   Sanger, Julia M ^a   Riley, Ian R ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; MARESIN 1; UNCLASSIFIED DRUG; 7,14-DIHYDROXYDOCOSA-4,8,10,12,16,19-HEXAENOIC ACID; DOCOSAHEXAENOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXUDATE; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; MASS FRAGMENTOGRAPHY; METABOLOME; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; ANIMAL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; DOCOSAHEXAENOIC ACIDS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; METABOLOME; MICE;

EID: 84996503283     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600837     Document Type: Article

References (37)

1. Cotran, R. S., V. Kumar, and T. Collins, eds. 1999. Robbins Pathologic Basis of Disease. W.B. Saunders Co., Philadelphia.
2. Tabas, I., and C. K. Glass. 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339: 166-172.
3. Serhan, C. N., N. Chiang, and J. Dalli. 2015. The resolution code of acute in-flammation: novel pro-resolving lipid mediators in resolution. Semin. Immunol. 27: 200-215.
4. Serhan, C. N., R. Yang, K. Martinod, K. Kasuga, P. S. Pillai, T. F. Porter, S. F. Oh, and M. Spite. 2009. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206: 15-23.
5. Serhan, C. N., J. Dalli, S. Karamnov, A. Choi, C. K. Park, Z. Z. Xu, R. R. Ji, M. Zhu, and N. A. Petasis. 2012. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26: 1755-1765.
6. Dalli, J., M. Zhu, N. A. Vlasenko, B. Deng, J. Z. Haeggström, N. A. Petasis, and C. N. Serhan. 2013. The novel 13S, 14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J. 27: 2573-2583.
7. Marcon, R., A. F. Bento, R. C. Dutra, M. A. Bicca, D. F. Leite, and J. B. Calixto. 2013. Maresin 1, a proresolving lipid mediator derived from omega-3 polyun-saturated fatty acids, exerts protective actions in murine models of colitis. J. Immunol. 191: 4288-4298.
8. Abdulnour, R. E., J. Dalli, J. K. Colby, N. Krishnamoorthy, J. Y. Timmons, S. H. Tan, R. A. Colas, N. A. Petasis, C. N. Serhan, and B. D. Levy. 2014. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc. Natl. Acad. Sci. USA 111: 16526-16531.
9. Dalli, J., and C. N. Serhan. 2012. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120: e60-e72.
10. Colas, R. A., M. Shinohara, J. Dalli, N. Chiang, and C. N. Serhan. 2014. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307: C39-C54.
11. Peters, M. F., and C. W. Scott. 2009. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J. Biomol. Screen. 14: 246-255.
12. Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. Yacoubian, C. H. Lee, R. Yang, N. A. Petasis, and C. N. Serhan. 2010. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA 107: 1660-1665.
13. Dalli, J., J. W. Winkler, R. A. Colas, H. Arnardottir, C. Y. C. Cheng, N. Chiang, N. A. Petasis, and C. N. Serhan. 2013. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 20: 188-201.
14. Chiang, N., G. Fredman, F. Bäckhed, S. F. Oh, T. Vickery, B. A. Schmidt, and C. N. Serhan. 2012. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484: 524-528.
15. Janes, K. A., and M. B. Yaffe. 2006. Data-driven modelling of signal-transduction networks. Nat. Rev. Mol. Cell Biol. 7: 820-828.
16. Wainwright, S. L., and W. S. Powell. 1991. Mechanism for the formation of dihydro metabolites of 12-hydroxyeicosanoids. Conversion of leukotriene B4 and 12-hydroxy-5, 8, 10, 14-eicosatetraenoic acid to 12-oxo intermediates. J. Biol. Chem. 266: 20899-20906.
17. Dess, D. B., and J. C. Martin. 1983. Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones. J. Org. Chem. 48: 4155-4156.
18. Falcone, R. C., and D. Aharony. 1990. Modulation of ligand binding to leuko-triene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents. J. Pharmacol. Exp. Ther. 255: 565-571.
19. Orr, S. K., R. A. Colas, J. Dalli, N. Chiang, and C. N. Serhan. 2015. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Am. J. Physiol. Lung Cell. Mol. Physiol. 308: L904-L911.
20. Deng, B., C. W. Wang, H. H. Arnardottir, Y. Li, C. Y. Cheng, J. Dalli, and C. N. Serhan. 2014. Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages. PLoS One 9: e102362.
21. Davies, L. C., M. Rosas, S. J. Jenkins, C. T. Liao, M. J. Scurr, F. Brombacher, D. J. Fraser, J. E. Allen, S. A. Jones, and P. R. Taylor. 2013. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat. Commun. 4: 1886.
22. Wang, C. W., R. A. Colas, J. Dalli, H. H. Arnardottir, D. Nguyen, H. Hasturk, N. Chiang, T. E. Van Dyke, and C. N. Serhan. 2015. Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive peri-odontitis leukocytes. Infect. Immun. 84: 658-665.
23. Yamada, T., Y. Tani, H. Nakanishi, R. Taguchi, M. Arita, and H. Arai. 2011. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J. 25: 561-568.
24. Majno, G., and I. Joris. 2004. Cells, Tissues, and Disease: Principles of General Pathology. Oxford University Press, New York.
25. Yokomizo, T., T. Izumi, T. Takahashi, T. Kasama, Y. Kobayashi, F. Sato, Y. Taketani, and T. Shimizu. 1993. Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leu-kotriene B4 12-hydroxydehydrogenase. J. Biol. Chem. 268: 18128-18135.
26. Soberman, R. J., T. W. Harper, R. C. Murphy, and K. F. Austen. 1985. Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 82: 2292-2295.
27. Ensor, C. M., J. Y. Yang, R. T. Okita, and H. H. Tai. 1990. Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxy-prostaglandin dehydrogenase. J. Biol. Chem. 265: 14888-14891.
28. Ensor, C. M., H. Zhang, and H. H. Tai. 1998. Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochem. J. 330: 103-108.
29. Sun, Y. P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282: 9323-9334.
30. Clària, J., J. Dalli, S. Yacoubian, F. Gao, and C. N. Serhan. 2012. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 189: 2597-2605.
31. Arita, M., S. F. Oh, T. Chonan, S. Hong, S. Elangovan, Y. P. Sun, J. Uddin, N. A. Petasis, and C. N. Serhan. 2006. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 281: 22847-22854.
32. Clish, C. B., B. D. Levy, N. Chiang, H.-H. Tai, and C. N. Serhan. 2000. Oxi-doreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J. Biol. Chem. 275: 25372-25380.
33. Tungen, J. E., M. Aursnes, A. Vik, S. Ramon, R. A. Colas, J. Dalli, C. N. Serhan, and T. V. Hansen. 2014. Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1. J. Nat. Prod. 77: 2241-2247.
34. Hong, S., T. F. Porter, Y. Lu, S. F. Oh, P. S. Pillai, and C. N. Serhan. 2008. Resolvin E1 metabolome in local inactivation during inflammation-resolution. J. Immunol. 180: 3512-3519.
35. Hansson, G., J. A. Lindgren, S. E. Dahlén, P. Hedqvist, and B. Samuelsson. 1981. Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett. 130: 107-112.
36. Chiang, N., J. Dalli, R. A. Colas, and C. N. Serhan. 2015. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J. Exp. Med. 212: 1203-1217.
37. Arita, M., T. Ohira, Y. P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan. 2007. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178: 3912-3917.